Over 26 weeks, including a dose-escalation period of up to 6 weeks, researchers observed mean percentage weight reductions of 6.0% to 10.8% across the cagrilintide dose groups compared to just 3.0% with placebo
Immunogen Recombinant human Glutathione S-transferase P Scientific Validation DataValidation Data (1) Anti-Glutathione S-transferase P Antibody (A41146) All lanes: Glutathione S-transferase P antibody at 2ug/ml
(PubMed) Cornelius N, Wardman JH, Hargreaves IP, et al
p53-pS15 is involved in regulating cell cycle arrest and apoptosis resistance in keloids Phospho-specific protein microarray was used to investigate the cell signaling profile in fibroblasts from keloid versus those from adjacent skin
Often doctors and therapists will use many of the same treatments that are available for other pain disorders, and adapt them e.g., as done in physical therapy
While making a decision on which path of action you want follow, answering these queries will ensure that both choices made are well informed hence leading into positive outcomes only
